You are here

Home

Clinical Trials: Urological Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, May 15, 2020 - 12:00
Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
Conditions:   BK Virus Infection;   Hemorrhagic Cystitis
Interventions:   Biological: Viralym-M;   Biological: Placebo
Sponsor:   AlloVir
Not yet recruiting
Posted: Friday, January 3, 2020 - 12:00
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy
Condition:   Type 2 Diabetes With Renal Manifestations
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Wednesday, December 11, 2019 - 12:00
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
Conditions:   Acute Kidney Injury;   Mesenchymal Stem Cells
Interventions:   Biological: Mesenchymal stem cells;   Other: Saline
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Thursday, December 5, 2019 - 12:00
Cell-based Therapy for the Treatment of Kidney Disease
Condition:   Kidney Diseases
Intervention:   Biological: endothelial progenitor cell
Sponsor:   Brigham and Women's Hospital
Not yet recruiting
Posted: Monday, October 14, 2019 - 12:00
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy
Conditions:   Mesenchymal Stem Cells;   Diabetic Nephropathy
Intervention:   Drug: Human umbilical cord mesenchymal stem cells
Sponsor:   Yan'an Affiliated Hospital of Kunming Medical University
Not yet recruiting
Posted: Friday, October 4, 2019 - 12:00
A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).
Conditions:   Chronic Kidney Disease;   Congenital Anomalies of Kidney and Urinary Tract
Intervention:   Biological: REACT - renal autologous cell therapy
Sponsors:   inRegen;   CTI Clinical Trial and Consulting Services
Recruiting
Posted: Friday, August 16, 2019 - 12:00
The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity Bladder
Conditions:   Stress Urinary Incontinence;   Overactive Bladder
Interventions:   Device: Sham arm;   Device: LiESWT arm
Sponsor:   Kaohsiung Medical University Chung-Ho Memorial Hospital
Recruiting
Posted: Monday, April 15, 2019 - 12:00
Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling
Condition:   Renal Artery Stenosis
Intervention:   Device: Low-energy extracorporeal ultrasound shockwave therapy (SWT)
Sponsors:   Mayo Clinic;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Posted: Wednesday, September 19, 2018 - 12:00
Intraurethral/Intravaginal 2940 nm Erbium Laser Treatment For Stress Urinary Incontinence
Condition:   Stress Urinary Incontinence
Interventions:   Device: Sham Fotona SP Dynamis;   Device: Intravaginal Fotona SP Dynamis;   Device: Intraurethral Fotona SP Dynamis
Sponsor:   Fotona d.o.o.
Recruiting
Posted: Wednesday, August 8, 2018 - 12:00
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Conditions:   Type 2 Diabetes Mellitus;   Obesity;   Bariatric Surgery Candidate;   Nephropathy;   Diabetic Kidney Disease;   Diabetes Mellitus, Type 2;   Diabetes Mellitus;   Diabetes Complications;   Weight Loss;   Diabetic Nephropathies;   Adolescent Obesity;   Pediatric Obesity
Interventions:   Drug: Aminohippurate Sodium Inj 20%;   Drug: Iohexol Inj 300 mg/mL;   Procedure: Vertical Sleeve Gastrectomy;   Procedure: Renal Biopsy
Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center
Recruiting

Pages